Table 4A.
Marketplace evaluation of Silver plans for coverage of obesity medication by State
| State | Silver plans provided no drug coveragea | |
|---|---|---|
| 1 | Alabama | ✓ |
| 2 | Alaska | ✓ |
| 3 | Arizona | — |
| 4 | Florida | ✓ |
| 5 | Georgia | ✓ |
| 6 | Indiana | ✓ |
| 7 | Kansas | ✓ |
| 8 | Louisiana | ✓ |
| 9 | Maine | ✓ |
| 10 | Mississippi | ✓ |
| 11 | Missouri | ✓ |
| 12 | Montana | ✓ |
| 13 | Nebraska | — |
| 14 | New Jersey | ✓ |
| 15 | North Carolina | — |
| 16 | North Dakota | — |
| 17 | Ohio | ✓ |
| 18 | Oklahoma | ✓ |
| 19 | Pennsylvania | ✓ |
| 20 | South Carolina | ✓ |
| 21 | South Dakota | — |
| 22 | Tennessee | ✓ |
| 23 | Texas | ✓ |
| 24 | Utah | ✓ |
| 25 | Virginia | — |
| 26 | Wisconsin | ✓ |
| 27 | Wyoming | ✓ |
| 28 | Arkansas | ✓ |
| 29 | Delaware | — |
| 30 | Illinois | ✓ |
| 31 | Iowa | — |
| 32 | Michigan | ✓ |
| 33 | New Hampshire | ✓ |
| 34 | West Virginia | — |
a
All four silver plans investigated for each state